Shopping Cart
- Remove All
- Your shopping cart is currently empty
BRD4/CK2-IN-1 is the first potent, orally active dual-target inhibitor of BRD4/CK2 (bromodomain-containing protein 4/casein kinase 2), with inhibitory concentrations (IC50) of 180 nM for BRD4 and 230 nM for CK2. In triple-negative breast cancer (TNBC), BRD4/CK2-IN-1 induces apoptosis and autophagy-related cell death.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
100 mg | $1,490 | 10-14 weeks | |
200 mg | $2,232 | 10-14 weeks |
Description | BRD4/CK2-IN-1 is the first potent, orally active dual-target inhibitor of BRD4/CK2 (bromodomain-containing protein 4/casein kinase 2), with inhibitory concentrations (IC50) of 180 nM for BRD4 and 230 nM for CK2. In triple-negative breast cancer (TNBC), BRD4/CK2-IN-1 induces apoptosis and autophagy-related cell death. |
Molecular Weight | 564.03 |
Formula | C29H30ClN5O5 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.